Skip to search formSkip to main contentSkip to account menu

BRL 26830A

Known as: BRL 26830, BRL-26830A, Benzoic acid, 4-(2-((2-hydroxy-2-phenylethyl)amino)propyl)-, methyl ester, (R*,R*)-(+-)-, (E)-2-butenedioate (2:1) (salt) 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Adrenergic beta-AgonistsEthanolaminesHypoglycemic Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Chronic Administration of BRL 26830A for 9 Weeks Improves Insulin Sensitivity but Does not Prevent Weight Gain in Gold-Thioglucose Obese Mice
BRL 26830A, a beta adrenoceptor agonist, has been shown to have antiobesity and antidiabetic properties in rodents. The aim of… 
1994
1994
Hyperplasia of brown adipose tissue after chronic stimulation of beta 3-adrenergic receptor in rats.
When mammals are exposed to a cold environment for a long time, the capacity of nonshivering thermogenesis by brown adipose… 
1991
1991
Anti-obesity and anti-diabetic actions of a beta 3-adrenoceptor agonist, BRL 26830A, in yellow KK mice.
The anti-obesity and anti-diabetic actions of BRL 26830A, beta 3-adrenoceptor agonist, (2 mg/kg administered intramuscularly… 
1991
1991
Psychological aspects of dietary weight loss and medication with the atypical beta agonist BRL 26830A in obese subjects.
Psychological aspects of dieting, including hunger and satiety sensations were explored in obese subjects during a placebo… 
1990
1990
Mitigation of obesity by BRL 26830A, a new beta-adrenoceptor agonist, in MSG obese mice.
Half of the mice in both the monosodium-L-glutamate (MSG)-induced obesity and saline control groups were given BRL 26830A via a… 
1989
1989
Effect of theβ-adrenoceptor agonist BRL 26830 on fatty acid synthesis and on the activities of pyruvate dehydrogenase and acetyl-CoA carboxylase in adipose tissues of the rat
BRL 26830 is a thermogenicβ-adrenoceptor agonist which stimulates lipolysis and fatty acid oxidationin vivo. It also stimulates… 
1988
1988
The effects of a new beta-adrenoceptor agonist BRL 26830A in refractory obesity.
Beta-adrenoceptor agonists have recently been shown to promote substantial loss of adipose tissue in laboratory animals. One of… 
1988
1988
Muscles of diabetic (db/db) mice: fibre size, fibre type and the effects of a thermogenic, beta-adrenoceptor agonist.
The size and morphological characteristics of muscles from diabetic obese (db/db) mice and their normal lean littermates were… 
1985
1985
Improved Glycemic Control in C57BI/KsJ (db/db) Mice After Treatment with the Thermogenic β-Adrenoceptor Agonist, BRL 26830
BRL 26830, (R*,R*)-(±)-methyl-4-(2-[{2-hydroxy-2-phenylethyl} amino]propyl)-benzoate, is a new type of β-adrenoceptor receptor… 
1985
1985
Brown adipose tissue is a major site of glucose utilisation in C57Bl/6 ob/ob mice treated with a thermogenic beta-adrenoceptor agonist.
Chronic treatment of C57Bl/6 ob/ob mice with the thermogenic beta-adrenoceptor agonist BRL 26830 increased the maximal activities… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)